BRAF and differentiated thyroid carcinoma: Individual statistical validation of HBME-1, galectin-3 expression, and BRAF V600E mutation in differentiating among papillary thyroid carcinoma, papillary thyroid hyperplasia, follicular adenoma, and follicular carcinoma.